Post-IPO Equity - Immunocore - Jul 18, 2022 Funding Round Profile - Cointime

Bitcoin $95,370.47 -1.63%
Ethereum $3,298.49 -0.99%
BNB $651.29 -1.24%
Optimism $1.77 +2.22%
Arbitrum $0.75 +1.38%
Solana $181.59 +1.03%
Polygon $0.48 +1.18%
Cosmos $6.47 -0.66%
Avalanche $36.75 -1.80%

Bitcoin $95,370.47 -1.63%
Ethereum $3,298.49 -0.99%
BNB $651.29 -1.24%
Optimism $1.77 +2.22%
Arbitrum $0.75 +1.38%
Solana $181.59 +1.03%
Polygon $0.48 +1.18%
Cosmos $6.47 -0.66%
Avalanche $36.75 -1.80%

Immunocore

company

Funding Round

Post-IPO Equity

Money Raised

$ 140M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
General Atlantic	-	-	-	Detail
Rock Springs Capital	-	-	-	Detail
RTW Investments	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jan 11, 2021	Series C	$ 75M	BlackRock	Detail
Jul 16, 2015	Series A	$ 320M	Eli Lilly,RTW Investments,etc.	Detail
Nov 5, 2012	Grant	£ 2.40M	Biomedical Catalyst Fund	Detail
Jan 11, 2021	Debt Financing	$ 100M	Oxford Finance LLC	Detail
Mar 2, 2020	Series B	$ 130M	Bill & Melinda Gates Foundation,CCB International,etc.	Detail
Sep 18, 2017	Series B	$ 40M	Bill & Melinda Gates Foundation	Detail
Feb 4, 2021	IPO	$ 258.31M		Detail